Filing Flows › Fate Therapeutics (FATE) › Recalls, complaints & regulation
Fate Therapeutics (FATE): clinical trials
Fate Therapeutics (FATE) beyond its filings: 6 active clinical trials.
Fate Therapeutics' latest quarter
Fate Therapeutics, Q2 2026: revenue $2.1M (+9% year over year), net loss $30.2M, operating cash flow −$23.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Fate Therapeutics have?
6 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.